Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs (Q34645841)

3 August 2017

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs (English)

1 reference

3 August 2017

3

James I Hudson

1 reference

3 August 2017

6

Harrison G Pope

1 reference

3 August 2017

2

Andrea R Sherwood

1 reference

3 August 2017

John H Halpern

1

1 reference

3 August 2017

Staci Gruber

series ordinal

4

1 reference

3 August 2017

David Kozin

series ordinal

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

15 February 2011

1 reference

3 August 2017

1 reference

3 August 2017

106

1 reference

3 August 2017

4

1 reference

3 August 2017

777-786

1 reference

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Overview of amphetamine-type stimulant mortality data--UK, 1997-2007.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

The harmful health effects of recreational ecstasy: a systematic review of observational evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Ecstasy (MDMA) and memory function: a meta-analytic update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

MDMA use and neurocognition: a meta-analytic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Behavioral control and resiliency in the onset of alcohol and illicit drug use: a prospective study from preschool to adolescence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Recent trends in drug abuse in China

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Pharmacological content of tablets sold as "ecstasy": results from an online testing service

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Neuropsychological function in ecstasy users: a study controlling for polydrug use.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

A rating scale for depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

An Inventory for Measuring Depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

The assessment of anxiety states by rating

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Altered states: the clinical effects of Ecstasy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Do multiple outcome measures require p-value adjustment?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Neuropsychological performance in long-term cannabis users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Insensitivity to future consequences following damage to human prefrontal cortex

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Multiple comparisons and related issues in the interpretation of epidemiologic data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Early-onset cannabis use and cognitive deficits: what is the nature of the association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Reflection impulsivity in current and former substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Self reported sleep quality and cognitive performance in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

The Purdue pegboard; norms and studies of reliability and validity.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Assessment of strategic self-regulation in traumatic brain injury: its relationship to injury severity and psychosocial outcome.

26 October 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

26 October 2018

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053129

Parent and Teacher Ratings of ADHD Symptoms: Psychometric Properties in a Community-Based Sample

26 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03252.X

Cannabis, cognition, and residual confounding

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21205042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1360-0443.2010.03252.X

1 reference

3 August 2017

1 reference

3 August 2017

1 reference